Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Abstract Background Nanoparticle albumin-bound (nab)-paclitaxel has better efficacy, safety profiles, and no need to use prophylactic steroids compared with solvent-based paclitaxel. We performed a single arm, phase II study to evaluate the efficacy and safety of weekly nab-paclitaxel and gemcitabin...

Full description

Bibliographic Details
Main Authors: Yannan Zhao, Fangfang Lv, She Chen, Zhonghua Wang, Jian Zhang, Sheng Zhang, Jun Cao, Leiping Wang, Enying Cao, Biyun Wang, Xichun Hu
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Metastatic breast cancer
Chemotherapy
Nab-paclitaxel
Gemcitabine
Caveolin-1
Online Access:http://link.springer.com/article/10.1186/s12885-018-4936-y

Internet

http://link.springer.com/article/10.1186/s12885-018-4936-y

Similar Items